- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06910917
The Effect of Roy Adaptation Model-Based Nursing Interventions on Psychological Resilience and Psychosocial Adjustment in Newly Diagnosed Breast Cancer Patients: A Randomized Controlled Trial
Yeni Tanı Almış Meme Kanseri Hastalarına Uygulanan Roy Adaptasyon Temelli Hemşirelik Müdahalelerinin Psikolojik Dayanıklılık ve Psikososyal Uyum Üzerine Etkisi
Study Overview
Status
Intervention / Treatment
Detailed Description
Breast cancer is one of the most common cancers among women in terms of incidence and mortality rates and continues to be a major public health problem that poses a threat to women's health. According to 2020 statistics, female breast cancer has overtaken lung cancer as the most commonly diagnosed cancer. With 19.3 million new cases and 10.0 million deaths in 2020, compared to 18.1 million cases and 9.6 million deaths in 2018, the global cancer burden is increasing.
With this rise in breast cancer incidence, patients are exposed to many treatment methods and their side effects, such as hormonal drugs, surgical interventions, radiotherapy and chemotherapy, which cause intense stress due to the development of new treatment methods needed. Depending on the stage of the disease and individual characteristics of patients with breast cancer, several of these treatments may be preferred at the same time. Patients are exposed to many systemic effects of these interventions and treatment toxicity. While the aim of these treatments is to prolong the life of the patients and enable them to live with better quality of life, the physical, psychological, social well-being and daily vital functions of the patients may be negatively affected due to the prolonged duration of the interventions and the occurrence of systemic toxic effects. In addition to its high incidence, breast cancer is a serious disease due to its physical, psychological and emotional effects on women. It is important to identify and meet the information needs of women in this situation. Meeting these needs can improve the quality of life of these women by increasing their adaptation to the disease, improving their coping skills, accelerating their return to daily life, and reducing their anxiety and depression.
This long treatment process in breast cancer treatment involves a chronic recovery process that includes physical deficiencies, psychological, occupational and sexual problems, with periods of recovery and exacerbation, creating short and long-term adaptation difficulties. In the literature, there are studies indicating that many of the symptoms seen after chemotherapy can be significantly reduced by counseling, education, care and coaching practices given to patients, and that this can be provided by nurses who are in constant communication with patients. The main goal of the supportive role of the nurse is to help patients understand, cope with and adapt to distressing situations. It is very important for nurses to provide holistic care to women diagnosed with breast cancer, to address all the problems experienced by the patient and to provide counseling for them. Psychiatric and psychosocial care and treatment in patients with medical illnesses are reported to improve patient care and quality, reduce mortality and morbidity, decrease hospitalization time and general costs, and contribute to improvement and well-being. Developing the ability to recognize behaviors that indicate the presence of psychosocial problems and to manage them effectively will not only contribute to the well-being of patients, but also increase the motivation of nurses to address and intervene in psychosocial problems.
One of the many methods used for holistic care is interventions using models in practice. The Roy Adaptation Model (RAM), which is one of the widely used models in nursing, sees the person as a bio-psychosocial being in constant interaction with a changing environment. The environment includes focal, contextual and residual stimuli. The focal stimulus is the person's confrontation with the internal and external environment. The individual immediately resists these internal and external stimuli. Nurses aim to manage the focal stimulus first and then the contextual stimuli. Contextual stimuli are other stimuli that contribute to the focal stimuli and affect the current situation. Residual stimuli are implicit factors that influence the current situation. These are beliefs, behaviors and personal experiences. In the Roy Adaptation Model, which argues that nurses make interventions that facilitate the individual's adaptation to the environment, four different areas of adaptation are defined. These areas are physiological domain, self-concept domain, role function domain and interdependence domain. In these four adaptation domains, the nurse aims to improve the patient's interaction with the environment, develop adaptive behaviors and adapt to non-adaptive behaviors.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Bornova
-
İzmir, Bornova, Turkey, 35040
- Ege University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Being a female aged 18 or older
- Having a confirmed breast cancer diagnosis within 0-6 months through clinical imaging and pathological examination
- Not having undergone surgery since the diagnosis or not having surgery planned within the study period (approximately 2 months) to exclude the impact of nursing care during surgical procedures
Exclusion Criteria:
- Non-primary breast cancer
- Presence of metastasis
- Receiving psychosocial treatment or therapy support
- Inability to attend sessions regularly
- Use of psychiatric medication within the last three months
- Having a low level of compliance
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Roy Adaptation Model-Based Nursing Interventions Group
A six-session program based on the Roy Adaptation Model was implemented for the experimental group, focusing on psychosocial adaptation (physiological, self-concept, role function, interdependence).
Standard nursing interventions from NIC were applied, including enhancing coping, self-esteem, body image, and functional abilities.
Outcomes were evaluated using NOC, and interventions were adjusted accordingly.
|
After the research groups were formed, a six-session interview program was created for the participants in the experimental group. Individual goals were set for the participants in the experimental group by combining the evaluations of the areas related to the psychosocial adaptation brought by the disease (physiological, self-concept, role function, interdependence) and the stimuli that would disrupt the adaptation (focus, affecting and possible) and nursing interventions were determined in line with these goals. applied. In the sessions, nursing and psychiatric nursing interventions (psychoeducation, relaxation, awareness, effective coping) based on the Roy Adaptation Model were carried out for the negative situations caused by anxiety and anxiety experienced by individuals. It was applied to the participants as standard. |
|
No Intervention: Control Group (without any intervention)
Description: The control group received standard nursing care without additional interventions based on the Roy Adaptation Model.
Their outcomes were monitored for comparison with the experimental group.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Psychosocial Adjustment to Illness Self-Report Scale (PAIS-SR)
Time Frame: Baseline (pre-test) and 6 weeks after the intervention (post-test)
|
After obtaining the necessary permissions, women who participated in the study between December 2022 and November 2023 were provided with detailed face-to-face explanations about the research, and their written informed consent was obtained.
The volunteers completed the scale forms in the hospital's psycho-oncology unit during six sessions, each lasting approximately 25-30 minutes.
|
Baseline (pre-test) and 6 weeks after the intervention (post-test)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Psychological Resilience Scale (PRS)
Time Frame: Baseline (pre-test) and 6 weeks after the intervention (post-test)
|
After obtaining the necessary permissions, women who participated in the study between December 2022 and November 2023 were provided with detailed face-to-face explanations about the research, and their written informed consent was obtained.
The volunteers completed the scale forms in the hospital's psycho-oncology unit during six sessions, each lasting approximately 25-30 minutes.
|
Baseline (pre-test) and 6 weeks after the intervention (post-test)
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- MSKU-SBF-AT-03
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Breast Cancer
-
Northwestern UniversityEisai Inc.UnknownMale Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative...United States
-
University of Southern CaliforniaNational Cancer Institute (NCI)WithdrawnStage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer
-
Oncoliq US IncRecruitingBreast Cancer Female | Breast Cancer Detection | Breast Cancer Early Stage Breast Cancer (Stage 1-3) | Breast Cancer With Low to Intermediate HER2 Expression | Breast Cancer - Female | Breast Cancer (Early Breast Cancer) | Breast Cancer - Ductal Carcinoma in Situ (DCIS) | Breast Cancer - Infiltrating...Argentina
-
University of California, IrvineNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedBreast Cancer | HER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | HER2-negative Breast CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedHER2-positive Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-positive Breast CancerUnited States
-
Joseph Baar, MD, PhDCompletedBreast Cancer | Stage I Breast Cancer | Inflammatory Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIIC Breast CancerUnited States
-
Case Comprehensive Cancer CenterNational Institute on Minority Health and Health Disparities (NIMHD)CompletedCancer Survivor | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast CancerUnited States
-
Baylor Breast Care CenterRecruitingBreast Cancer | Breast Neoplasm | Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | HER2-positive Breast Cancer | Breast Cancer Stage II | Breast Cancer Female | Breast Cancer Stage III | Estrogen Receptor-positive Breast Cancer | Hormone Receptor-positive Breast Cancer | Breast Cancer InvasiveUnited States
-
Innocrin PharmaceuticalCompletedBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Male Breast Cancer | ER+ Breast Cancer | Cancer of the BreastUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedInflammatory Breast Cancer | Male Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast CancerUnited States
Clinical Trials on Roy Adaptation-Based Nursing Interventions
-
Balikesir UniversityUludag UniversityCompletedAdolescent | Type 1 Diabetes
-
Izmir Katip Celebi UniversityCompletedAddiction, AlcoholTurkey
-
YaNi PengCompleted
-
Istanbul University - Cerrahpasa (IUC)Not yet recruitingNurse's Role | Nutritional Deficiency | Adaptation Reaction
-
Mersin UniversityCompletedSocial Media AddictionTurkey
-
Cyprus International UniversityCompletedQuality of Life | Osteoarthritis | Knee | Care Model | Nursing InterventionsTurkey
-
Gaziantep Islam Science and Technology UniversityCompletedStress Disorders, Post-Traumatic | Hemodialysis Complication | Psychosocial Impairment | Self NeglectTurkey
-
Mersin Training and Research HospitalCompletedMental Health | MindfulnessTurkey
-
Ege UniversityCompletedOutpatients | Defibrillators, ImplantableTurkey
-
Joint Shantou International Eye Center of Shantou...CompletedDiabetic Retinopathy | Diabetic Retinal DiseaseChina